Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024
Amicus Therapeutics (Nasdaq: FOLD) has announced its participation in three major investor conferences in November 2024. The company will present at the Guggenheim Healthcare Innovation Conference in Boston on November 12 at 2:30 p.m. ET and the Jefferies London Healthcare Conference on November 19 at 8:00 a.m. GMT. Management will also attend the J.P. Morgan Equity Opportunities Forum on November 13.
Live audio webcasts of the presentations will be available through the investors section of the Amicus Therapeutics website. The company focuses on developing and delivering medicines for rare diseases, maintaining a strong commitment to patient care and advancing its pipeline of first- or best-in-class medicines.
Amicus Therapeutics (Nasdaq: FOLD) ha annunciato la sua partecipazione a tre importanti conferenze per investitori nel novembre 2024. L'azienda presenterà alla Guggenheim Healthcare Innovation Conference a Boston il 12 novembre alle 14:30 ET e alla Jefferies London Healthcare Conference il 19 novembre alle 8:00 GMT. La direzione parteciperà anche al J.P. Morgan Equity Opportunities Forum il 13 novembre.
Le trasmissioni audio in diretta delle presentazioni saranno disponibili attraverso la sezione dedicata agli investitori del sito web di Amicus Therapeutics. L'azienda si concentra sullo sviluppo e la fornitura di medicinali per malattie rare, mantenendo un forte impegno per la cura dei pazienti e promuovendo la sua pipeline di medicinali di prima o migliore classe.
Amicus Therapeutics (Nasdaq: FOLD) ha anunciado su participación en tres importantes conferencias de inversores en noviembre de 2024. La empresa presentará en la Guggenheim Healthcare Innovation Conference en Boston el 12 de noviembre a las 2:30 p.m. ET y en la Jefferies London Healthcare Conference el 19 de noviembre a las 8:00 a.m. GMT. La dirección también asistirá al J.P. Morgan Equity Opportunities Forum el 13 de noviembre.
Las transmisiones de audio en vivo de las presentaciones estarán disponibles a través de la sección para inversores del sitio web de Amicus Therapeutics. La empresa se centra en desarrollar y proporcionar medicamentos para enfermedades raras, manteniendo un fuerte compromiso con el cuidado del paciente y avanzando en su cartera de medicamentos de primera o mejor clase.
Amicus Therapeutics (Nasdaq: FOLD)는 2024년 11월에 열리는 세 개의 주요 투자자 회의에 참여한다고 발표했습니다. 이 회사는 11월 12일 오후 2시 30분 ET에 보스턴에서 열리는 Guggenheim Healthcare Innovation Conference와 11월 19일 오전 8시 GMT에 열리는 Jefferies London Healthcare Conference에서 발표할 예정입니다. 경영진은 11월 13일에 열리는 J.P. Morgan Equity Opportunities Forum에도 참석할 것입니다.
프레젠테이션의 실시간 오디오 웹캐스트는 Amicus Therapeutics 웹사이트의 투자자 섹션을 통해 제공될 예정입니다. 이 회사는 희귀 질병을 위한 의약품 개발 및 제공에 집중하고 있으며, 환자 돌봄에 대한 강력한 헌신을 유지하고 있으며, 일류 또는 최고 품질의 의약품 파이프라인을 발전시키고 있습니다.
Amicus Therapeutics (Nasdaq: FOLD) a annoncé sa participation à trois grandes conférences pour investisseurs en novembre 2024. L'entreprise présentera lors de la Guggenheim Healthcare Innovation Conference à Boston le 12 novembre à 14h30 ET et lors de la Jefferies London Healthcare Conference le 19 novembre à 8h00 GMT. La direction assistera également au J.P. Morgan Equity Opportunities Forum le 13 novembre.
Des webcasts audio en direct des présentations seront disponibles via la section investisseurs du site web d'Amicus Therapeutics. L'entreprise se concentre sur le développement et la fourniture de médicaments pour les maladies rares, tout en maintenant un engagement fort envers les soins aux patients et en avançant son pipeline de médicaments de première ou meilleure classe.
Amicus Therapeutics (Nasdaq: FOLD) hat seine Teilnahme an drei wichtigen Investorenkonferenzen im November 2024 angekündigt. Das Unternehmen wird am 12. November um 14:30 Uhr ET auf der Guggenheim Healthcare Innovation Conference in Boston und am 19. November um 8:00 Uhr GMT auf der Jefferies London Healthcare Conference präsentieren. Das Management wird auch am 13. November am J.P. Morgan Equity Opportunities Forum teilnehmen.
Die Live-Audio-Webcasts der Präsentationen werden im Bereich für Investoren auf der Website von Amicus Therapeutics verfügbar sein. Das Unternehmen konzentriert sich auf die Entwicklung und Bereitstellung von Medikamenten für seltene Krankheiten und legt großen Wert auf die Patientenversorgung sowie den Ausbau seiner Pipeline von erstklassigen oder besten Medikamenten.
- None.
- None.
PRINCETON, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in November.
- Guggenheim Healthcare Innovation Conference in Boston, MA, on Tuesday, November 12, 2024, at 2:30 p.m. ET
- Jefferies London Healthcare Conference in London, U.K. on Tuesday, November 19, 2024, at 8:00 a.m. GMT
A live audio webcast of each presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.
Additionally, management will attend the J.P. Morgan Equity Opportunities Forum on Wednesday, November 13, 2024.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.
CONTACT:
Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809
Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079
FOLD–G
FAQ
When is Amicus Therapeutics (FOLD) presenting at the Guggenheim Healthcare Conference in November 2024?
Where can investors watch Amicus Therapeutics (FOLD) conference presentations in November 2024?
What investor conferences will Amicus Therapeutics (FOLD) attend in November 2024?
